The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Home | Video pages | Webcast | Screening, prevention and treatment of post-transplant diabetes mellitus (PTDM)

Screening, prevention and treatment of post-transplant diabetes mellitus (PTDM)

DESCarTES Working Group

Access the article here

Speaker
Yassine Laghrib, Belgium

Panellists
Ivana Dedinska, Slovakia
Elisabeth Schwaiger, Austria

Moderator
Rachel Hellemans, Belgium